Mayflower Financial Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,635
| Closed | -$204K | – | 349 |
|
|
2023
Q3 | $204K | Buy |
+5,635
| New | +$204K | 0.03% | 317 |
|
|
2022
Q3 | – | Sell |
-5,395
| Closed | -$294K | – | 346 |
|
|
2022
Q2 | $294K | Buy |
5,395
+25
| +0.5% | +$1.36K | 0.05% | 251 |
|
|
2022
Q1 | $292K | Buy |
5,370
+36
| +0.7% | +$1.96K | 0.04% | 273 |
|
|
2021
Q4 | $294K | Buy |
5,334
+222
| +4% | +$12.2K | 0.04% | 271 |
|
|
2021
Q3 | $250K | Buy |
5,112
+34
| +0.7% | +$1.66K | 0.03% | 284 |
|
|
2021
Q2 | $253K | Sell |
5,078
-699
| -12% | -$34.8K | 0.03% | 267 |
|
|
2021
Q1 | $258K | Sell |
5,777
-352
| -6% | -$15.7K | 0.04% | 248 |
|
|
2020
Q4 | $282K | Buy |
+6,129
| New | +$282K | 0.05% | 215 |
|